Stoke Therapeutics Inc (STOK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 4,894 | 4,831 | 4,216 | 2,801 | 3,308 |
| Gross Profit | 4,894 | 4,831 | 4,216 | 2,801 | 3,308 |
| Operating Expenses | 34,897 | 34,173 | 32,588 | 32,388 | 30,542 |
| Operating Income | -30,003 | -29,342 | -28,372 | -29,587 | -27,234 |
| Other Income | 3,573 | 3,647 | 1,998 | 2,629 | 2,692 |
| Pre-tax Income | -26,430 | -25,695 | -26,374 | -26,958 | -24,542 |
| Net Income Continuous | -26,430 | -25,695 | -26,374 | -26,958 | -24,542 |
| Net Income | $-26,430 | $-25,695 | $-26,374 | $-26,958 | $-24,542 |
| EPS Basic Total Ops | -0.47 | -0.46 | -0.57 | -0.61 | -0.55 |
| EPS Basic Continuous Ops | -0.47 | -0.46 | -0.57 | -0.60 | -0.55 |
| EPS Diluted Total Ops | -0.47 | -0.46 | -0.57 | -0.61 | -0.55 |
| EPS Diluted Continuous Ops | -0.47 | -0.46 | -0.57 | -0.60 | -0.55 |
| EPS Diluted Before Non-Recurring Items | -0.47 | -0.46 | -0.57 | N/A | N/A |
| EBITDA(a) | $-30,010 | $-29,083 | $-27,833 | $-29,052 | $-26,719 |